| Home | E-Submission | Sitemap | Contact Us |  
Korean J Clin Oncol. 2005;1(1): 8-26.
Current status of chemotherapy for colorectal cancer
SeongTaek Oh
Dept. of Surgery, Kangnam St. Mary’s Hospital, Seoul, Korea
결장암 항암요법의 최신지견
가톨릭대학교 의과대학 강남성모병원 외과
Corresponding Author: SeongTaek Oh ,Tel: 82-2-590-2781, Fax: 82-2-590-1406, Email: stoh@catholic.ac.kr
Received: May 15, 2005;  Accepted: June 20, 2005.
Share :  
Colorectal cancer is one of the leading cancers in Western countries. Despite recent progress made in treatment of colorectal cancer, a large proportion with this disease develop local recurrences or distant metastases. The management of these patients requires a multidisciplinary approach. Surgery must be performed whenever possible for metastases confined to the liver or lung. However, in most cases, chemotherapy and supportive care are the only feasible treatments. Since the 1990s, the emergence of new drugs has modified the prognosis of metastatic colorectal cancer. This malignant disease has largely benefited from the development of new drugs and new therapeutic concepts, such as oral chemotherapy or targeted biotherapy. Although a significant improvement in survival has been reached with these new therapeutic approaches, there is not yet a gold standard chemotherapy regimen for patients with advanced colorectal cancer, particularly the best sequence of drug administration This review describes how the research has been conducted in the medical management of advanced colorectal cancer and steps towards the goal of better understanding and anticipating new treatments in colorectal cancer.
Keywords: Colorectal Neoplasm | Chemotherapy
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : ksco2004@daum.net

Copyright© Korean Society of Surgical Oncology.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers